(HealthDay)—A sickle cell disease prevention and treatment program in the United States has been reauthorized to receive nearly $5 million each year over the next five years.
Dec 20, 2018
0
0
UNSW Australia researchers have shown that changing just a single letter of the DNA of human red blood cells in the laboratory increases their production of oxygen-carrying haemoglobin - a world-first advance that could lead ...
May 14, 2015
0
138
Mississippi lawmakers are sending their governor a bill that would create a medical marijuana program for people with serious medical conditions.
Jan 27, 2022
0
3
Hematology researchers at The Children's Hospital of Philadelphia have manipulated key biological events in adult blood cells to produce a form of hemoglobin normally absent after the newborn period. Because this fetal hemoglobin ...
Dec 8, 2013
0
0
A Yale-led research team used a new gene editing strategy to correct mutations that cause thalassemia, a form of anemia. Their gene editing technique provided corrections to the mutations and alleviated the disease in mice, ...
Oct 26, 2016
0
58
(HealthDay)—People with severe pain from cancer or sickle cell anemia should not be denied coverage for opioid painkillers, a new clarification on federal guidelines states.
Apr 9, 2019
0
5
Malaria claims hundreds of thousands of lives each year—mainly children, and especially in Africa. It is one of the leading causes of death by an infectious agent, the Plasmodium falciparum parasite. In research on malaria, ...
Mar 1, 2019
0
12
Imagine a system that can detect within one second whether a newborn baby has jaundice, a condition affecting 60 percent of infants, and in severe cases leading to brain damage and hearing loss.
Nov 17, 2021
0
21
In a study tracking the severe crisis pain of sickle cell disease and its management in 73 adults over a period of a year, Johns Hopkins researchers found that even among those on high doses of daily at-home opioids, a persistent ...
Nov 27, 2018
0
19
Researchers at the National Institutes of Health have developed a new and improved viral vector—a virus-based vehicle that delivers therapeutic genes—for use in gene therapy for sickle cell disease. In advanced lab tests ...
Oct 2, 2019
0
11
